Could there be a global frame work for clinical trials?

The European Medicines Agency has suggested there should be a global framework for clinical trials. They pointed out that only 38.8% of all participants in clinical trials in the UK, the remainder of the participants are located throughout the world, as reported by Pharma Tech.

Thomas Lönngren, Executive Director of the EMA, said:
“What is needed is a robust framework for the oversight and conduct of clinical trials, no matter where in the world the clinical investigator’s sites are located and patients recruited. The Agency is committed to build and extend its relationship with regulators in all parts of the world and with international organisations to work to standards agreed and recognised by all.”